Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasmin Nouri

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal for Immunotherapy of Cancer|November 20, 2021
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cellsYasmin Nouri, Robert Weinkove, Rachel Perret
Current Protocols|August 22, 2023
An In Vitro Model to Assess CRS Potential of CAR T Cells Using a Tumor Cell Line and Autologous MonocytesYasmin Nouri, Robert Weinkove, Rachel Perret
Cancers|January 11, 2022
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle TraffickingTom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, et al.
Cancers|September 22, 2019
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient CellsNicola Bougen-Zhukov, Yasmin Nouri, Tanis Godwin, et al.
Scientific Reports|May 2, 2025
TIRE-seq simplifies transcriptomics via integrated RNA capture and library preparationPiper O'Keeffe, Yasmin Nouri, Hui Shi Saw, et al.
The Lancet. Oncology|August 8, 2020
Hereditary diffuse gastric cancer: updated clinical practice guidelinesVanessa R Blair, Maybelle McLeod, Fátima Carneiro, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal for Immunotherapy of Cancer|November 20, 2021
T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cellsYasmin Nouri, Robert Weinkove, Rachel Perret
Current Protocols|August 22, 2023
An In Vitro Model to Assess CRS Potential of CAR T Cells Using a Tumor Cell Line and Autologous MonocytesYasmin Nouri, Robert Weinkove, Rachel Perret
Cancers|January 11, 2022
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle TraffickingTom Brew, Nicola Bougen-Zhukov, Wilson Mitchell, et al.
Cancers|September 22, 2019
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient CellsNicola Bougen-Zhukov, Yasmin Nouri, Tanis Godwin, et al.
Scientific Reports|May 2, 2025
TIRE-seq simplifies transcriptomics via integrated RNA capture and library preparationPiper O'Keeffe, Yasmin Nouri, Hui Shi Saw, et al.
The Lancet. Oncology|August 8, 2020
Hereditary diffuse gastric cancer: updated clinical practice guidelinesVanessa R Blair, Maybelle McLeod, Fátima Carneiro, et al.
Pageof 1